DNA double-strand break repair, immunodeficiency and the RIDDLE syndrome

Expert Review of Clinical Immunology

Volumn 7, Issue 2, 2011, Pages 169-185

  Blundred, Rachel M ^a   Stewart, Grant S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

53BP1; ataxia telangiectasia; DNA damage response; DNA double strand break repair; immunodeficiency; Nijmegen breakage syndrome; radiosensitive severe combined immunodeficiency; RIDDLE syndrome; RNF168

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; DOUBLE STRANDED DNA; PROTEIN RNF 168; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA; DNA RECOMBINATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; HUMAN; IMMUNE DEFICIENCY; NIJMEGEN BREAKAGE SYNDROME; PROTEIN FUNCTION; RADIOSENSITIVITY; RIDDLE SYNDROME; SIGNAL TRANSDUCTION;

BODY DYSMORPHIC DISORDERS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPAIR-DEFICIENCY DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEARNING DISORDERS; MUTATION; RADIATION TOLERANCE; UBIQUITIN-PROTEIN LIGASES;

EID: 79953125125     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.10.93     Document Type: Article

References (140)

1. Hopfner KP, Craig L, Moncalian G et al. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature 418(6897), 562-566 (2002). (Pubitemid 34851405)
2. Williams RS, Moncalian G, Williams JS et al. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell 135(1), 97-109 (2008).
3. Uziel T, Lerenthal Y, Moyal L et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612-5621 (2003). (Pubitemid 37279970)
4. Burma S, Chen BP, Murphy M et al. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276, 42462-42467 (2001).
5. Stucki M, Clapperton JA, Mohammad D et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123, 1213-1226 (2005). (Pubitemid 41821780)
6. Stewart GS, Wang B, Bignell CR et al. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421, 961-966 (2003). (Pubitemid 36288029)
7. Lukas C, Melander F, Stucki M et al. MDC1 couples DNA double-strand break recognition by NBN with its H2AXdependent chromatin retention. EMBO J. 23, 2674-2683 (2004). (Pubitemid 38988238)
8. Huen MS, Grant R, Manke I et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131, 901-914 (2007). (Pubitemid 350138083)
9. Kolas NK, Chapman JR, Nakada S et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640 (2007). (Pubitemid 350233664)
10. Mailand N, Bekker-Jensen S, Faustrup H et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887-900 (2007). (Pubitemid 350138084)
11. Kim H, Chen J, Yu X. Ubiquitin-binding protein RAP80 mediates BRCA1- dependent DNA damage response. Science 316, 1202-1205 (2007). (Pubitemid 46877484)
12. Sobhian B, Shao G, Lilli DR et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316, 1198-1202 (2007). (Pubitemid 46877483)
13. Wang B, Matsuoka S, Ballif BA et al. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316, 1194-1198 (2007). (Pubitemid 46877482)
14. Feng L, Huang J, Chen J. MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev. 23(6), 719-728 (2009).
15. Shao G, Patterson-Fortin J, Messick TE et al. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev. 23(6), 740-754 (2009).
16. Wang B, Hurov K, Hofmann K, Elledge SJ. NBA1, a new player in the BRCA1 A complex, is required for DNA damage resistance and checkpoint control. Genes Dev. 23(6), 729-739 (2009).
17. Shao G, Lilli DR, Patterson-Fortin J et al. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8- Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc. Natl Acad. Sci. USA 106(9), 3166-3171 (2009).
18. Polanowska J, Martin JS, Garcia-Muse T et al. A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J. 25, 2178-2188 (2006).
19. Botuyan MV, Lee J, Ward IM et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 127(7), 1361-1373 (2006). (Pubitemid 44960409)
20. Schotta G, Sengupta R, Kubicek S et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 22(15), 2048-2061 (2008).
21. DiTullio RA Jr, Mochan TA, Venere M et al. 53BP1 functions in an ATMdependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell. Biol. 4, 998-1002 (2004). (Pubitemid 35469432)
22. Difilippantonio S, Gapud E, Wong N et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 456, 529-533 (2008). Highlights a role for 53BP1 in regulating nonhomologous DNA end-joining. (Pubitemid 50304846)
23. Bunting SF, Callén E, Wong N et al. 53BP1 inhibits homologous recombination in BRAC1-deficient cells by blocking resection of DNA breaks. Cell 141(2), 243-254 (2010). Demonstration that loss of 53BP1 can restore the repair of DNA damage in BRCA1-deficient cells.
24. Yata K, Esashi F. Dual role of Cdks in DNA repair: To be, or not to be. DNA repair (Amst). 8(1), 6-18 (2009).
25. Huertas P. DNA resection in eukaryotes: Deciding how to fix the break. Nat. Struct. Mol. Biol. 17(1), 11-16 (2010).
26. Sartori AA, Lukas C, Coates J et al. Human CtIP promotes DNA end resection. Nature 450(7169), 509-514 (2007). First demonstration that CtIP functions with the hMre11/hRad50/NBN complex to regulate DNA end resection. (Pubitemid 350190253)
27. Huertas P, Jackson SP. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J. Biol. Chem. 284(14), 9558-9565 (2009).
28. Chen L, Nievera CJ, Lee AY, Wu X. Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J. Biol. Chem. 283(12), 7713-7720 (2008).
29. Yun MH, Hiom K. CtIP-BRCA1 modulates the choice of DNA doublestrand- break repair pathway throughout the cell cycle. Nature 459(7245), 460-463 (2009).
30. Bouwman P, Aly A, Escandell JM et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17(6), 688-695 (2010).
31. Cao L, Xu X, Bunting SF et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol. Cell 35(4), 534-541 (2009).
32. Gravel S, Chapman JR, Magill C, Jackson SP. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev. 22(20), 2767-2772 (2008).
33. Nimonkar AV, Ozsoy AZ, Genschel J et al. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc. Natl Acad. Sci. USA 105(44), 16906-16911 (2008).
34. Wyman C, Kanaar R. DNA double-strand break repair: All's well that ends well. Annu. Rev. Genet. 40, 363-383 (2006). (Pubitemid 44956790)
35. Mimitou EP, Symington LS. Nucleases and helicases take center stage in homologous recombination. Trends Biochem. Sci. 34(5), 264-272 (2009).
36. Muñoz IM, Hain K, Déclais A-C et al. Coordination of structure-specific nucleases by human SLX4/BTB12 is required for DNA repair. Mol. Cell 35, 116-127 (2009).
37. Klein H, Symington L. Breaking up just got easier to do. Cell 138(1), 20-22 (2009).
38. Aguilera A, Gómez-González B. Genome instability: A mechanistic view of its causes and consequences. Nat. Rev. Genet. 9(3), 204-217 (2008). (Pubitemid 351271797)
39. Kühne M, Riballo E, Rief N et al. A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res. 64(2), 500-508 (2004). (Pubitemid 38120888)
40. Mari PO, Florea BI, Persengiev SP et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl Acad. Sci. USA 103(49), 18597-18602 (2006). (Pubitemid 44913456)
41. Uematsu N, Weterings E, Yano K et al. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA doublestrand breaks. J. Cell. Biol. 177(2), 219-229 (2007). (Pubitemid 46658634)
42. Chan DW, Chen BP-C, Prithivirajsingh S et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 16(18), 2333-2338 (2002). (Pubitemid 35034402)
43. Ding Q, Reddy YVR, Wang W et al. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol. Cell Biol. 23(16), 5836-5848 (2003). (Pubitemid 36951345)
44. Calsou P, Frit P, Humbert O et al. The DNA-dependent protein kinase catalytic activity regulates DNA end processing by means of Ku entry into DNA. J. Biol. Chem. 274(12), 7848-7856 (1999).
45. Weterings E, Verkaik NS, Brüggenwirth HT et al. The role of DNA dependent protein kinase in synapsis of DNA ends. Nucleic Acids Res. 31(24), 7238-7246 (2003). (Pubitemid 38008452)
46. Meek K, Douglas P, Cui X et al. Transautophosphorylation at DNA-dependent protein kinase's two major autophosphorylation site clusters facilitates end processing but not end joining. Mol. Cell Biol. 27(10), 3881-3890 (2007). (Pubitemid 46726193)
47. Mahajan KN, Gangi-Peterson L, Sorscher DH et al. Association of terminal deoxynucleotidyl transferase with Ku. Proc. Natl Acad. Sci. USA 96(24), 13926-13931 (1999).
48. Mahajan KN, McElhinny SAN, Mitchell BS, Ramsden DA. Association of DNA polymerase μ (pol μ) with Ku and ligase IV: Role for pol μ in end-joining doublestrand break repair. Mol. Cell Biol. 22(14), 5194-5202 (2002). (Pubitemid 34700708)
49. Ma Y, Pannicke U, Schwarz K, Lieber MR. Hairpin opening and overhang processing by an Artemis/ DNA-dependent protein kinase complex in non-homologous end joining and V(D) J recombination. Cell 108(6), 781-794 (2002). (Pubitemid 34327530)
50. Gu J, Lu H, Tsai AG et al. Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: Influence of terminal DNA sequence. Nucleic Acids Res. 35(17), 5755-5762 (2007). (Pubitemid 47506292)
51. Tsai CJ, Kim SA, Chu G. Cernunnos/ XLF promotes the ligation of mismatched and noncohesive DNA ends. Proc. Natl Acad. Sci. USA 104(19), 7851-7856 (2007). (Pubitemid 47185840)
52. Boboila C, Yan C, Wesemann DR et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J. Exp. Med. 207(2), 417-427 (2010).
53. Boboila C, Jankovic M, Yan CT et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc. Natl Acad. Sci. USA 107(7), 3034-3039 (2010).
54. Simsek D, Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol. 17(4), 410-416 (2010).
55. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109(Suppl.), S45-S55 (2002). (Pubitemid 34457851)
56. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol. 24, 541-570 (2006).
57. Chaudhuri J, Alt FW. Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4, 541-552 (2004). (Pubitemid 38931769)
58. Franco S, Alt FW, Manis JP. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair (Amst). 5(9-10), 1030-1041 (2006). (Pubitemid 44308467)
59. Muramatsu M, Kinoshita K, Fagarasan S et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102(5), 553-563 (2000).
60. Revy P, Muto T, Levy Y et al. Activationinduced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102(5), 565-575 (2000).
61. Chaudhuri J, Tian M, Khuong C et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422(6933), 726-730 (2003). (Pubitemid 36514112)
62. Sohail A, Klapacz J, Samaranayake M et al. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31(12), 2990-2994 (2003). (Pubitemid 37441756)
63. Daniel JA, Santos MA, Wang Z et al. PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science 329(5994), 914-915 (2010).
64. Chaudhuri J, Alt F. Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4(7), 541-552 (2004). (Pubitemid 38931769)
65. Lumsden JM, McCarty T, Petiniot LK et al. Immunoglobulin class switch recombination is impaired in ATM-deficient mice. J. Exp. Med. 200(9), 1111-1121 (2004). (Pubitemid 39507051)
66. Pan Q, Petit-Frére C, Lähdesmäki A et al. Alternative end joining during switch recombination in patients with ataxiatelangiectasia. Eur. J. Immunol. 32(5), 1300-1308 (2002). (Pubitemid 34546257)
67. Reina-San-Martin B, Chen HT, Nussenzweig A, Nussenzweig MC. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 200(9), 1103-1110 (2004). (Pubitemid 39507050)
68. Lähdesmäki A, Taylor AM, Chrzanowska KH, Pan-Hammarström Q. Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem. 279(16), 16479-16487 (2004). (Pubitemid 38509346)
69. Kracker S, Bergmann Y, Demuth I et al. Nibrin functions in Ig class-switch recombination. Proc. Natl Acad. Sci. USA 102(5), 1584-1589 (2005). (Pubitemid 40209211)
70. Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking NBN. Proc. Natl Acad. Sci. USA 102(5), 1590-1595 (2005). (Pubitemid 40209212)
71. Reina-San-Martin B, Difilippantonio S, Hanitsch L et al. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197, 1767-1778 (2003). (Pubitemid 36745351)
72. Lou Z, Minter-Dykhouse K, Franco S et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 21, 187-200 (2006). (Pubitemid 43099935)
73. Li L, Halaby MJ, Hakem A et al. RNF8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer. J. Exp. Med. 207(5), 983-997 (2010). First in vivo model of RNF8 deficiency demonstrating a role for RNF8 in regulating class switch recombination.
74. Santos MA, Huen MS, Jankovic M et al. Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J. Exp. Med. 207(5), 973-981 (2010). First in vivo model of RNF8 deficiency demonstrating a role for RNF8 in regulating class switch recombination.
75. Manis JP, Morales JC, Xia Z et al. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol. 5, 481-487 (2004). Demonstration of a role for 53BP1 in regulating class switch recombination. (Pubitemid 38660459)
76. Ward IM, Reina-San-Martin B, Olaru A et al. 53BP1 is required for class switch recombination. J. Cell Biol. 165, 459-464 (2004). Demonstration of a role for 53BP1 in regulating class switch recombination. (Pubitemid 38679611)
77. Staples ER, McDermott EM, Reiman A et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin. Exp. Immunol. 153(2), 214-220 (2008). (Pubitemid 351989158)
78. Khanna KK, Yan J, Watters D et al. Defective signaling through the B cell antigen receptor in Epstein-Barr virustransformed ataxia-telangiectasia cells. J. Biol. Chem. 272(14), 9489-9495 (1997). (Pubitemid 27154965)
79. Giovannetti A, Mazzetta F, Caprini E et al. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood 100(12), 4082-4089 (2002). (Pubitemid 35396876)
80. Vacchio MS, Olaru A, Livak F, Hodes RJ. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor a locus coding end breaks. Proc. Natl Acad. Sci. USA 104(15), 6323-6328 (2008). (Pubitemid 47186093)
81. Bredemeyer AL, Sharma GG, Huang CY et al. ATM stabilizes DNA double-strandbreak complexes during V(D)J recombination. Nature 442, 466-470 (2006). (Pubitemid 44264797)
82. Aurias A, Dutrillaux B, Buriot D, Lejeune J. High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia. Mutat. Res. 69(2), 369-374 (1980). (Pubitemid 10128582)
83. Mahowald GK, Baron JM, Mahowald MA et al. Aberrantly resolved RAG-mediated DNA breaks in ATM-deficient lymphocytes target chromosomal breakpoints in cis. Proc. Natl Acad. Sci. USA 106(43), 18339-18344 (2009).
84. Carney JP, Maser RS, Olivares H et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 93(3), 477-486 (1998). First identification of hNBN mutations in a human DNA repair deficiency syndrome. (Pubitemid 28232091)
85. Varon R, Vissinga C, Platzer M et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93(3), 467-476 (1998). First identification of hNBN mutations in a human DNA repair deficiency syndrome. (Pubitemid 28232090)
86. Weemaes CM, Smeets DF, van der Burgt CJ. Nijmegen Breakage syndrome: A progress report. Int. J. Radiat. Biol. 66(Suppl. 6), S185-S188 (1994).
87. Chrzanowska KH, Kleijer WJ, Krajewska- Walasek M et al. Eleven Polish patients with microcephaly, immunodeficiency, and chromosomal instability: The Nijmegen breakage syndrome. Am. J. Med. Genet. 57(3), 462-471 (1995).
88. Gregorek H, Chrzanowska KH, Michalkiewicz J et al. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: An 8-year follow-up study in a single centre. Clin. Exp. Immunol. 130(2), 319-324 (2002). (Pubitemid 35286221)
89. Digweed M, Sperling K. Nijmegen breakage syndrome: Clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst). 3(8-9), 1207-1217 (2004). (Pubitemid 38997964)
90. Deriano L, Stracker TH, Baker A et al. Roles for NBN in alternative nonhomologous end-joining of V(D)J recombination intermediates. Mol. Cell 34(1), 13-25 (2009).
91. Helmink BA, Bredemeyer AL, Lee BS et al. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J. Exp. Med. 206(3), 669-679 (2009).
92. Stewart GS, Maser RS, Stankovic T et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99(6), 577-587 (1999). First identification of hMRE11 mutations in a human DNA repair deficiency syndrome. (Pubitemid 30004634)
93. Delia D, Piane M, Buscemi G et al. MRE11 mutations and impaired ATMdependent responses in an Italian family with ataxia-telangiectasia-like disorder. Hum. Mol. Genet. 13(18), 2155-2163 (2004). (Pubitemid 39377837)
94. Fernet M, Gribaa M, Salih MA et al. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum. Mol. Genet. 14(2), 307-318 (2005).
95. Waltes R, Kalb R, Gatei M et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am. J. Hum. Genet. 84(5), 605-616 (2009). First identification of hRAD50 mutations in a human DNA repair deficiency syndrome.
96. Shull ER, Lee Y, Nakane H et al. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 23(2), 171-180 (2009).
97. Warcoin M, Lespinasse J, Despouy G et al. Fertility defects revealing germline biallelic nonsense NBN mutations. Hum. Mutat. 30(3), 424-430 (2009).
98. Riballo E, Critchlow SE, Teo SH et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol. 9(13), 699-702 (1999). (Pubitemid 29332352)
99. O'Driscoll M, Cerosaletti KM, Girard PM et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8(6), 1175-1185 (2001). (Pubitemid 34084990)
100. Ben-Omran TI, Cerosaletti K, Concannon P et al. A patient with mutations in DNA Ligase IV: Clinical features and overlap with Nijmegen breakage syndrome. Am. J. Med. Genet. A. 137A(3), 283-287 (2005). (Pubitemid 41262661)
101. Buck D, Moshous D, de Chasseval R et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur. J. Immunol. 36(1), 224-235 (2006). (Pubitemid 43116409)
102. Enders A, Fisch P, Schwarz K et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J. Immunol. 176(8), 5060-5068 (2006).
103. van der Burg M, van Veelen LR, Verkaik NS et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J. Clin. Invest. 116(1), 137-145 (2006). (Pubitemid 43121798)
104. Toita N, Hatano N, Ono S et al. Epstein- Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am. J. Med. Genet. A. 143(7), 742-745 (2007). (Pubitemid 46606685)
105. Pan-Hammarström Q, Jones AM, Lähdesmäki A et al. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J. Exp. Med. 201(2), 189-194 (2005). (Pubitemid 40189427)
106. Moshous D, Callebaut I, de Chasseval R et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105(2), 177-186 (2001). (Pubitemid 32429508)
107. Li L, Moshous D, Zhou Y et al. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J. Immunol. 168(12), 6323-6329 (2002). (Pubitemid 34620054)
108. Kobayashi N, Agematsu K, Sugita K et al. Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families. Hum. Genet. 112(4), 348-352 (2003). (Pubitemid 36869062)
109. Moshous D, Pannetier C, Chasseval Rd R et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J. Clin. Invest. 111(3), 381-387 (2003). (Pubitemid 36182215)
110. Noordzij JG, Verkaik NS, van der Burg M et al. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. Blood 101(4), 1446-1452 (2003). (Pubitemid 36182519)
111. Ege M, Ma Y, Manfras B et al. Omenn syndrome due to ARTEMIS mutations. Blood. 105(11), 4179-4186 (2005). (Pubitemid 40720760)
112. Pannicke U, Hönig M, Schulze I, et al. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events. Hum. Mutat. 31(2), 197-207 (2010).
113. Ahnesorg P, Smith P, Jackson SP. LF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124(2), 301-313 (2006). (Pubitemid 43121979)
114. Buck D, Malivert L, de Chasseval R et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124(2), 287-299 (2006). (Pubitemid 43121978)
115. Dutrannoy V, Demuth I, Baumann U et al. Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Hum. Mutat. 31(9), 1059-1068 (2010).
116. Rooney S, Sekiguchi J, Zhu C et al. Leaky SCID phenotype associated with defective V(D)J coding end processing in Artemisdeficient mice. Mol. Cell 10(6), 1379-1390 (2002). (Pubitemid 36050879)
117. Rooney S, Alt FW, Lombard D et al. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med. 197(5), 553-565 (2003). (Pubitemid 36314651)
118. Du L, van der Burg M, Popov SW et al. Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination. J. Exp. Med. 205(13), 3031-3040 (2008).
119. Blunt T, Finnie NJ, Taccioli GE et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine SCID mutation. Cell 80(5), 813-823 (1995).
120. Shin EK, Perryman LE, Meek K. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J. Immunol. 158(8), 3565-3569 (1997). (Pubitemid 127488707)
121. van der Burg M, Ijspeert H, Verkaik NS et al. A DNA-PKCS mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J. Clin. Invest. 119(1), 91-98 (2009).
122. Nussenzweig A, Chen C, da Costa Soares V et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382(6591), 551-555 (1996). (Pubitemid 26260699)
123. Gu Y, Seidl KJ, Rathbun GA et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7(5), 653-665 (1997). (Pubitemid 28156633)
124. Li G, Nelsen C, Hendrickson EA. Ku86 is essential in human somatic cells. Proc. Natl Acad. Sci. USA 99(2), 832-837 (2002). (Pubitemid 34106596)
125. Stewart GS, Stankovic T, Byrd PJ et al. RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc. Natl Acad. Sci. USA 104, 16910-16915 (2007). Identification of RIDDLE syndrome as a new human immunodeficiency disorder associated with defective repair of DNA double-strand breaks. (Pubitemid 350210964)
126. Stewart GS, Panier S, Townsend K et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136, 420-434 (2009). Identification of mutations in RNF168 as the causative genetic defect in RIDDLE syndrome.
127. Penengo L, Mapelli M, Murachelli AG et al. Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. Cell 124, 1183-1195 (2006).
128. Doil C, Mailand N, Bekker-Jensen S et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136, 435-446 (2009).
129. Bekker-Jensen S, Rendtlew Danielsen J, Fugger K et al. HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat. Cell. Biol. 12(1), 80-86 (2010).
130. Boulton SJ. DNA repair: Decision at the break point. Nature 465(7296), 301-302 (2010).
131. Bothmer A, Robbiani DF, Feldhahn N et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J. Exp. Med. 207(4), 855-865 (2010).
132. Lavin MF. Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9(10), 759-769 (2008).
133. Laine A, Topisirovic I, Zhai D et al. Regulation of p53 localization and activity by Ubc13. Mol. Cell Biol. 26(23), 8901-8913 (2006). (Pubitemid 44851948)
134. Topisirovic I, Gutierrez GJ, Chen M et al. Control of p53 multimerization by Ubc13 is JNK-regulated. Proc. Natl Acad. Sci. USA 106(31), 12676-12681 (2009).
135. Laribee RN, Fuchs SM, Strahl BD. H2B ubiquitylation in transcriptional control: A FACT-finding mission. Genes Dev. 21(7), 737-743 (2007). (Pubitemid 46572353)
136. Weake VM, Workman JL. Histone ubiquitination: Triggering gene activity. Mol. Cell 29(6), 653-663 (2008). (Pubitemid 351400924)
137. Wang H, Wang L, Erdjument-Bromage H et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431(7010), 873-878 (2004). (Pubitemid 39434086)
138. Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20(6), 845-854 (2005). (Pubitemid 41814874)
139. Zhou W, Zhu P, Wang J et al. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol. Cell 29(1), 69-80 (2008).
140. Wu J, Huen MS, Lu LY et al. Histone ubiquitination associates with BRCA1- dependent DNA damage response. Mol. Cell Biol. 29(3), 849-860 (2009).